معرفی
Kimberly L. Johung, MD, PhD is an Associate Professor of Therapeutic Radiology at Yale School of Medicine, holding multiple leadership positions including Vice Chair for Education, Director of the Residency Training Program, Chief of the Gastrointestinal Radiotherapy Program, and Chief of the VA Radiotherapy Program. She practices at Smilow Cancer Hospital and provides radiation oncology services at the Veteran Affairs Connecticut Healthcare System in West Haven.
Dr. Johung completed her medical education at Yale University School of Medicine (MD, 2008) and earned her PhD from Yale University (2007). Her residency training was at Yale-New Haven Hospital (2013) following an internship there in 2009. Her undergraduate degree (BA) is also from Yale University (1999).
Her primary research focus centers on gastrointestinal cancers, including esophageal, gastric, pancreatic, hepatic, rectal, and anal cancers, with special expertise in stereotactic body radiotherapy (SBRT) for tumors of the chest and abdomen. She also treats lung cancer, head and neck cancer, and prostate cancer. Her research aims to define molecular markers using retrospective studies, clinical trials, and translational research to guide treatment decisions and improve outcomes for patients with gastrointestinal malignancies. She is particularly interested in integrating biology-guided radiotherapy approaches and optimizing treatment protocols through clinical trials.
Analysis of Dr. Johung's recent publication record reveals a strong focus on gastrointestinal malignancies, particularly pancreatic, rectal, and esophageal cancers. Her work spans clinical guidelines development (NCCN), translational research on molecular biomarkers, technical innovations in radiotherapy delivery (including SBRT and biology-guided radiotherapy), and clinical trial design. A notable trend is her increasing involvement in multi-institutional collaborations and national guideline committees, reflecting her growing influence in the field of radiation oncology for gastrointestinal cancers.
Dr. Johung is an active participant in national cancer guideline development, serving on NCCN panels for Esophageal and Gastric Cancers. Her clinical expertise has been recognized through inclusion in Yale Medicine's 'Top Doctors' lists. She is also a member of the American Society for Radiation Oncology, contributing to the advancement of the field through professional engagement.
As Director of the Residency Training Program, Dr. Johung oversees the education and development of future radiation oncologists at Yale. She has led research on resident evaluation methods and faculty assessment across radiation oncology programs nationally. Her clinical trials portfolio includes studies on stereotactic body radiation therapy for oligoprogression on immune checkpoint inhibitors in metastatic renal cell carcinoma (as Principal Investigator) and participation as Sub Investigator in trials for MRI brain surveillance versus prophylactic cranial irradiation in small-cell lung cancer and dose-deescalated SBRT for centrally located lung cancer.
Dr. Johung is affiliated with multiple research teams including the Center for Gastrointestinal Cancers, DNA Damage and Genome Integrity team, Gastrointestinal Radiotherapy Program, Pancreatic Diseases Program, and Prostate & Genitourinary Radiotherapy team at Yale Cancer Center. These affiliations reflect her collaborative approach to cancer research and treatment across multiple disciplines within the Yale ecosystem.
